0000880771-17-000059.txt : 20170317 0000880771-17-000059.hdr.sgml : 20170317 20170317172925 ACCESSION NUMBER: 0000880771-17-000059 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170315 FILED AS OF DATE: 20170317 DATE AS OF CHANGE: 20170317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000880771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943116852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 BUSINESS PHONE: 650-358-3456 MAIL ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Low Raymond Anthony CENTRAL INDEX KEY: 0001391388 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19825 FILM NUMBER: 17699171 MAIL ADDRESS: STREET 1: 25 SHADOW TREE CT CITY: DANVILLE STATE: CA ZIP: 94506 4 1 certent-form4.xml PRIMARY DOCUMENT X0306 4 2017-03-15 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001391388 Low Raymond Anthony 950 TOWER ROAD, SUITE 900 FOSTER CITY CA 94404 0 1 0 0 VP, Finance & Controller Common Stock 2017-03-15 4 M 0 1250 0 A 13513 D Restricted Stock Unit 0 2017-03-15 4 M 0 1250 0 A 2026-03-15 Common Stock 1250 22500 D Includes 613 shares and 742 shares purchased under the Issuer's Employee Stock Purchase Plan on August 31, 2016 and February 29, 2017, respectively. Granted under the Issuer's 2015 Equity Incentive Plan. Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Vesting for such RSUs will occur 25% on March 15, 2017, 25% on March 15, 2018, 25% on March 15, 2019, and 25% on March 15, 2020, contingent upon the executive's continued employment. /s/ Raymond A. Low 2017-03-17